Urmila Chandran
Overview
Explore the profile of Urmila Chandran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
802
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kilpatrick K, Cahill K, Chandran U, Riskin D
Epidemiology
. 2024 Nov;
36(1):20-27.
PMID: 39589014
Background: Asthma is a phenotypically complex disease requiring nuanced data to generate clinically and scientifically robust real-world evidence. A quantitative measure of data quality is important for variables key to...
2.
Lee K, Liu Z, Chandran U, Kalsekar I, Laxmanan B, Higashi M, et al.
JMIR AI
. 2024 Jun;
2:e44537.
PMID: 38875565
Background: Ground-glass opacities (GGOs) appearing in computed tomography (CT) scans may indicate potential lung malignancy. Proper management of GGOs based on their features can prevent the development of lung cancer....
3.
Rajaram R, Huang Q, Li R, Chandran U, Zhang Y, Amos T, et al.
Chest
. 2023 Dec;
165(5):1260-1270.
PMID: 38065405
Background: Standard treatment for early-stage or locoregionally advanced non-small cell lung cancer (NSCLC) includes surgical resection. Recurrence after surgery is commonly reported, but a summary estimate for postsurgical recurrence-free survival...
4.
Chandran U, Reps J, Yang R, Vachani A, Maldonado F, Kalsekar I
Cancer Epidemiol Biomarkers Prev
. 2022 Dec;
32(3):337-343.
PMID: 36576991
Background: This study used machine learning to develop a 3-year lung cancer risk prediction model with large real-world data in a mostly younger population. Methods: Over 4.7 million individuals, aged...
5.
Chandran U, Reps J, Stang P, Ryan P
PLoS One
. 2019 Dec;
14(12):e0226255.
PMID: 31851711
Background: Confounding by disease severity is an issue in pharmacoepidemiology studies of rheumatoid arthritis (RA), due to channeling of sicker patients to certain therapies. To address the issue of limited...
6.
Geldhof A, Slater J, Clark M, Chandran U, Coppola D
Drug Saf
. 2019 Nov;
43(2):147-161.
PMID: 31677004
Background: Women of childbearing potential are often treated with monoclonal antibodies to control chronic and debilitating inflammatory diseases. Remicade (innovator infliximab [IFX]) may cross the placenta after the first trimester...
7.
Bandera E, Chandran U, Hong C, Troester M, Bethea T, Adams-Campbell L, et al.
Breast Cancer Res Treat
. 2015 Mar;
150(3):655-66.
PMID: 25809092
African American (AA) women are more likely than white women to be obese and to be diagnosed with ER- and triple-negative (TN) breast cancer, but few studies have evaluated the...
8.
Chandran U, McCann S, Zirpoli G, Gong Z, Lin Y, Hong C, et al.
Nutr Cancer
. 2014 Sep;
66(7):1187-99.
PMID: 25265504
Limiting energy-dense foods, fast foods, and sugary drinks that promote weight gain is a cancer prevention recommendation, but no studies have evaluated intake in relation to breast cancer risk in...
9.
Trabert B, Ness R, Lo-Ciganic W, Murphy M, Goode E, Poole E, et al.
J Natl Cancer Inst
. 2014 Feb;
106(2):djt431.
PMID: 24503200
Background: Regular aspirin use is associated with reduced risk of several malignancies. Epidemiologic studies analyzing aspirin, nonaspirin nonsteroidal anti-inflammatory drug (NSAID), and acetaminophen use and ovarian cancer risk have been...
10.
Charbonneau B, Block M, Bamlet W, Vierkant R, Kalli K, Fogarty Z, et al.
Cancer Res
. 2013 Nov;
74(3):852-61.
PMID: 24272484
A missense single-nucleotide polymorphism (SNP) in the immune modulatory gene IL1A has been associated with ovarian cancer risk (rs17561). Although the exact mechanism through which this SNP alters risk of...